Fig. 6 | Signal Transduction and Targeted Therapy

Fig. 6

From: Spi-1 proto-oncogene regulates mRNA hypertranscription and malignant progression in head and neck cancer

Fig. 6The alternative text for this image may have been generated using AI.

SPI1 promotes mRNA hypertranscription in HNSCC through a time-dependent mechanism. Representative images (a) and quantification (b) of EU incorporation in CAL27 and CAL33 cells after stable knockdown of SPI1 using two independent shRNAs (n = 3 independent replicates). Red: EU-labeled nascent RNA; blue: DAPI-stained nuclei. Scale bar, 100 μm. c Relative per-cell mRNA yield in CAL27 and CAL33 cells, determined after mRNA purification and normalized by cell number (n = 3 independent replicates). Representative EU-stained images (d) and quantification (e) of SAS and FaDu cells with or without SPI1 overexpression (n = 3 independent replicates). f Relative per-cell mRNA yield in SPI1-overexpressing SAS and FaDu cells, based on poly(A)-selected RNA quantification (n = 3 independent replicates). g Time-course RT‒qPCR analysis of SPI1 expression in Dox-inducible Tet-ON SAS and FaDu cells following doxycycline treatment (n = 3 independent replicates). The data were normalized to that of GAPDH and expressed relative to 0 h. h Immunoblot analysis of the SPI1 and c-MYC protein levels. Representative images (i) and quantification of the fluorescence intensity (j) of cells with incorporated EU at the indicated time points after Dox induction (n = 3 independent replicates). The data are presented as the mean ± SD. Scale bars, 50 μm. In (a–c), the shNC group indicates cells transduced with a lentiviral vector carrying nontargeting shRNA. In (d–f), the NC group indicates cells transduced with an empty lentiviral vector as the control for SPI1 overexpression. Statistical significance was determined using one-way ANOVA followed by Tukey’s post hoc test or an unpaired two-tailed Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001

Back to article page